Earnings Per Share (EPS) of $1.20, surpassing the estimated $1.17, reflecting the company’s ability to exceed market expectations. Revenue reached approximately $34.1 billion, exceeding forecasts and ...

Roche projects mid-single digit group sales growth in 2025, with core EPS growth in the high-single digit range. The company expects a CHF1.2 billion impact from the loss of exclusivity but aims to ...

Teva Pharmaceutical Industries TEVA reported fourth-quarter 2024 adjusted earnings of 71 cents per share, which beat the ...

GNT is a closed-end fund focused on natural resources and gold, using covered call options and leverage to generate high income and capital appreciation. Despite attractive sector positioning and a ...

Infineon Technologies AG has launched the OPTIGA™ Connect Consumer OC1230, a cutting-edge eSIM solution designed to reduce energy consumption by ...

Chinese biotech Ascentage Pharma has taken the first US biotech initial public offering (IPO) of 2025 over the finish line, ...

EARNINGS FORECAST: Roche's core earnings per share are expected to come in at 18.59 francs, according to the Visible Alpha consensus. For 2023, the company reported core EPS of 18.57 francs. As of ...

Moog Inc. (NYSE: MOG.A and MOG.B), a worldwide designer, manufacturer and systems integrator of high-performance precision motion and fluid controls and control ...

Decided to add this retail giant to your portfolio? Here's what you need to know before buying Amazon stock. Many, or all, of the products featured on this page are from our advertising partners ...

Report from the Institute for Scientific Information shows how academic research drives global innovation and benefits society LONDON, Jan. 30, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.